Receptor reserve of phosphoinositide-coupled muscarinic receptors in mouse hippocampus in vivo

被引:8
作者
Bymaster, FP [1 ]
Carter, PA [1 ]
DeLapp, NW [1 ]
Calligaro, DO [1 ]
Felder, CC [1 ]
机构
[1] Lilly Corp Ctr, Neurosci Res Div, Indianapolis, IN 46285 USA
关键词
muscarinic M-1 receptor; phosphoinositide hydrolysis; receptor reserve; muscarinic agonist; pilocarpine;
D O I
10.1016/S0006-8993(01)02889-X
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The ability of the partial muscarinic agonist pilocarpine to increase in vivo phosphoinositide. (PI) hydrolysis in mouse brain was compared to two full agonists. Pilocarpine increased in vivo phosphoinositide (PI) hydrolysis in cortex, striatum, and to the greatest extent in the hippocampus. Pilocarpine injected either subcutaneously or intracerebroventricularly robustly increased in vivo PI hydrolysis in hippocampus up to 500% of control levels and the increases were blocked by the muscarinic antagonist scopolamine. The increases in vivo PI hydrolysis induced by pilocarpine, were 60-75% of the magnitude of the full muscarinic agonists oxotremorine-M and cis-dioxolane. The muscarinic. M-1 preferring antagonist pirenzepine potently blocked pilocarpine-induced increases in in vivo PI hydrolysis, consistent with the increase being mediated by M-1 receptors. Since pilocarpine is a relatively weak partial agonist, these data suggest a substantial level of receptor reserve for the PI response in mouse hippocampus. (C) 2001 Published by Elsevier Science B.V.
引用
收藏
页码:165 / 171
页数:7
相关论文
共 35 条
[21]   IMMUNOLOGICAL LOCALIZATION OF M1-M5 MUSCARINIC ACETYLCHOLINE-RECEPTORS IN PERIPHERAL-TISSUES AND BRAIN [J].
LEVEY, AI .
LIFE SCIENCES, 1993, 52 (5-6) :441-448
[22]   Activation of the genetically defined m1 muscarinic receptor potentiates N-methyl-D-aspartate (NMDA) receptor currents in hippocampal pyramidal cells [J].
Marino, MJ ;
Rouse, ST ;
Levey, AI ;
Potter, LT ;
Conn, PJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (19) :11465-11470
[23]   LOSS OF M2 MUSCARINE RECEPTORS IN THE CEREBRAL-CORTEX IN ALZHEIMERS-DISEASE AND EXPERIMENTAL CHOLINERGIC DENERVATION [J].
MASH, DC ;
FLYNN, DD ;
POTTER, LT .
SCIENCE, 1985, 228 (4703) :1115-1117
[24]  
MCKINNEY M, 1989, MOL PHARMACOL, V35, P39
[25]  
MCKINNEY M, 1993, PROG BRAIN RES, V98, P333
[26]   NO RESPONSE TO HIGH-DOSE MUSCARINIC AGONIST THERAPY IN ALZHEIMERS-DISEASE [J].
MOURADIAN, MM ;
MOHR, E ;
WILLIAMS, JA ;
CHASE, TN .
NEUROLOGY, 1988, 38 (04) :606-608
[27]   THE MUSCARINIC RECEPTOR AGONIST L-658,903 MODULATES THE IN-VIVO ACCUMULATION OF INOSITOL MONOPHOSPHATES IN MOUSE-BRAIN [J].
PATEL, S ;
FREEDMAN, SB .
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1994, 267 (03) :329-334
[28]   COUPLING OF M1-MUSCARINIC RECEPTORS TO G-PROTEIN IN ALZHEIMER-DISEASE [J].
PEARCE, BD ;
POTTER, LT .
ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1991, 5 (03) :163-172
[29]   DIFFERENTIAL REGULATION OF PI HYDROLYSIS AND ADENYLYL CYCLASE BY MUSCARINIC RECEPTOR SUBTYPES [J].
PERALTA, EG ;
ASHKENAZI, A ;
WINSLOW, JW ;
RAMACHANDRAN, J ;
CAPON, DJ .
NATURE, 1988, 334 (6181) :434-437
[30]  
Porter AC, 2001, LIFE SCI, V68, P2624